Screener
BioCryst Pharmaceuticals BCRX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from BioCryst Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's net margin?
- BioCryst Pharmaceuticals (BCRX) reported net margin of -40.9% in Q2 2026.
- How has BioCryst Pharmaceuticals's net margin changed year-over-year?
- BioCryst Pharmaceuticals's net margin decreased by 538.5% year-over-year, from -6.4% to -40.9%.
- What is the long-term trend for BioCryst Pharmaceuticals's net margin?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's net margin has grown at a -50.6% compound annual growth rate (CAGR), from -1,026.4% to 30.2%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about BioCryst Pharmaceuticals's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude